Ignite Creation Date:
2024-05-06 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05366504
Status:
UNKNOWN
Last Update Posted:
2022-05-09
First Post:
2022-05-04
Brief Title:
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment
Sponsor:
Institute for the Study of Urological Diseases Greece
Organization:
Institute for the Study of Urological Diseases Greece
Study Overview
Official Title:
Is Combined Low Intensity Shockwave Therapy LiST Plus Platelet-rich Plasma PRP Injection Therapy Better Than LiST Monotherapy for the Improvement of Erectile Function a Double-blind Randomized Placebo-controlled Clinical Trial
Status:
UNKNOWN
Status Verified Date:
2022-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We designed a double blind randomized sham-controlled trial in order to investigate and compare the treatment efficacy of LiST plus PRP intracorporeal injection vs LiST plus placebo normal saline intracorporeal injection in men with moderate and mild to moderate vasculogenic ED as measured by IIEF-EF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None